Cogentix Medical (NASDAQ: CGNT) reported Q3 EPS of $0.21, $0.11 better than the analyst estimate of $0.10. Revenue for the quarter came in at $118.4 million versus the consensus estimate of $114.83 million.

GUIDANCE:

Cogentix Medical sees FY2022 EPS of $0.80, versus the consensus of $0.88. Cogentix Medical sees FY2022 revenue of $480 million, versus the consensus of $451 million.

For earnings history and earnings-related data on Cogentix Medical (CGNT) click here.